ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CYAD Celyad Oncology SA

0.651
0.001 (0.15%)
22 Nov 2024 - Closed
Delayed by 15 minutes

Celyad Oncology Financial Summary

The current CYAD market cap is 26.97M. The company's latest EPS is EUR -0.2039 and P/E is -3.19.

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 6k5k00102k
Operating Income -28.88M-16.99M-26.39M-40.86M-9.54M
Net Income -28.63M-17.2M-26.51M-40.94M-8.45M
Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 89.84M66.08M79.94M19.72M16.28M
Total Liabilities 44.22M35.09M36.3M15.4M9.98M
Total Equity 45.62M30.99M43.64M4.32M6.3M

Cash Flow

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -28.2M-27.67M-26.64M-28.01M-15.2M
Investing 8.99M157k-126k7.2M407k
Financing 18.28M5.4M39.52M3.24M9.36M
Market Cap 26.97M
Price to Earnings Ratio -3.19
Price to Sales Ratio 260
Price to Cash Ratio 3.84
Price to Book Ratio 4.27
Dividend Yield -

Share Statistics

Shares Outstanding 41.43M
Average Volume (1 week) 91.79k
Average Volume (1 Month) 189.89k
52 Week Change 25.68%
52 Week High 1.22
52 Week Low 0.212
Spread (Intraday) 0.03 (4.13%)

Company Info

Company Name Celyad Oncology SA
Address axis business park
mont-saint-guibert, walloon brabant 1435
Website https://www.celyad.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock